A Noninvasive Method for Quantifying Cerebral Metabolic Rate of Oxygen by Hybrid PET/MRI: Validation in a Porcine Model.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 33741647.
- Also identified by DOI 10.2967/jnumed.120.260521 and PMC identifier 8612192.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The gold standard for imaging the cerebral metabolic rate of oxygen (CMRO<sub>2</sub>) is positron emission tomography (PET); however, it is an invasive and complex procedure that also requires correction for recirculating <sup>15</sup>O-H<sub>2</sub>O and the blood-borne activity. We propose a noninvasive reference-based hybrid PET/magnetic resonance imaging (MRI) method that uses functional MRI techniques to calibrate <sup>15</sup>O-O<sub>2</sub>-PET data. Here, PET/MR imaging of oxidative metabolism (PMROx) was validated in an animal model by comparison to PET-alone measurements. Additionally, we investigated if the MRI-perfusion technique arterial spin labelling (ASL) could be used to further simplify PMROx by replacing <sup>15</sup>O-H<sub>2</sub>O-PET, and if the PMROx was sensitive to anesthetics-induced changes in metabolism. <b>Methods:</b> <sup>15</sup>O-H<sub>2</sub>O and <sup>15</sup>O-O<sub>2</sub> PET data were acquired in a hybrid PET/MR scanner (3 T Siemens Biograph mMR), together with simultaneous functional MRI (OxFlow and ASL), from juvenile pigs (<i>n</i> = 9). Animals were anesthetized with 3% isoflurane and 6 mL/kg/h propofol for the validation experiments and arterial sampling was performed for PET-alone measurements. PMROx estimates were obtained using whole-brain (WB) CMRO<sub>2</sub> from OxFlow and local cerebral blood flow (CBF) from either noninvasive <sup>15</sup>O-H<sub>2</sub>O-PET or ASL (PMROxASL). Changes in metabolism were investigated by increasing the propofol infusion to 20 mL/kg/h. <b>Results:</b> Good agreement and correlation were observed between regional CMRO<sub>2</sub> measurements from PMROx and PET-alone. No significant differences were found between OxFlow and PET-only measurements of WB oxygen extraction fraction (0.30 ± 0.09 and 0.31 ± 0.09) and CBF (54.1 ± 16.7 and 56.6 ± 21.0 mL/100 g/min), or between PMROx and PET-only CMRO<sub>2</sub> estimates (1.89 ± 0.16 and 1.81 ± 0.10 mLO<sub>2</sub>/100 g/min). Moreover, PMROx and PMROxASL were sensitive to propofol-induced reduction in CMRO<sub>2</sub> <b>Conclusion:</b> This study provides initial validation of a noninvasive PET/MRI technique that circumvents many of the complexities of PET CMRO<sub>2</sub> imaging. PMROx does not require arterial sampling and has the potential to reduce PET imaging to <sup>15</sup>O-O<sub>2</sub> only; however, future validation involving human participants are required.